A caution regarding U-500 insulin by continuous subcutaneous infusion

Endocr Pract. Mar-Apr 2004;10(2):163-4. doi: 10.4158/EP.10.2.163.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects*
  • Infusion Pumps
  • Insulin / administration & dosage*
  • Insulin / adverse effects*
  • Insulin Infusion Systems*
  • Insulin Resistance*

Substances

  • Hypoglycemic Agents
  • Insulin